(Q36885184)

16 August 2017

1 reference

title

Molecular targets for disrupting leukocyte trafficking during multiple sclerosis (English)

1 reference

16 August 2017

Erin E McCandless

1

1 reference

16 August 2017

Robyn S Klein

series ordinal

2

1 reference

16 August 2017

publication date

19 July 2007

1 reference

Expert Reviews in Molecular Medicine

16 August 2017

published in

1 reference

16 August 2017

volume

9

1 reference

16 August 2017

issue

20

1 reference

16 August 2017

page(s)

1-19

1 reference

The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

Changes in serum levels of ICAM and TNF-R correlate with disease activity in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

Overlapping roles of P-selectin and alpha 4 integrin to recruit leukocytes to the central nervous system in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

P-selectin glycoprotein ligand 1 is not required for the development of experimental autoimmune encephalomyelitis in SJL and C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

The beta chemokines CCL4 and CCL5 enhance adhesion of specific CD4+ T cell subsets to human brain endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

Regulation of Th1 and Th2 lymphocyte migration by human adult brain endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

Efficient recruitment of lymphocytes in inflamed brain venules requires expression of cutaneous lymphocyte antigen and fucosyltransferase-VII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

An open label study of the effects of rituximab in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

Cutting edge: macrophage migration inhibitory factor is necessary for progression of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

The protective effect of 17beta-estradiol on experimental autoimmune encephalomyelitis is mediated through estrogen receptor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

Oral feeding with ethinyl estradiol suppresses and treats experimental autoimmune encephalomyelitis in SJL mice and inhibits the recruitment of inflammatory cells into the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

The expression and function of chemokines involved in CNS inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

PSGL-1 is not required for development of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Treatment with chimeric anti-human CD40 antibody suppresses MRI-detectable inflammation and enlargement of pre-existing brain lesions in common marmosets affected by MOG-induced EAE.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Role of glucocorticoids on T cell recruitment across the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Blood-brain barrier disruption in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

The adhesion molecule and cytokine profile of multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Lovastatin reduces apoptosis and downregulates the CD40 expression induced by TNF-alpha in cerebral vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Multiple sclerosis--the plaque and its pathogenesis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

TNFR1-dependent VCAM-1 expression by astrocytes exposes the CNS to destructive inflammation

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Cloning, sequence comparison and in vivo expression of the gene encoding rat P-selectin

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Diapedesis of monocytes is associated with MMP-mediated occludin disappearance in brain endothelial cells

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients with multiple sclerosis: cICAM-1 is an indicator for relapse

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

TNF accelerates the onset but does not alter the incidence and severity of myelin basic protein-induced experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Statins and the vascular endothelial inflammatory response

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

The safety and efficacy of IFN-beta products for the treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside attenuates experimental autoimmune encephalomyelitis via modulation of endothelial-monocyte interaction

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

GSNO attenuates EAE disease by S-nitrosylation-mediated modulation of endothelial-monocyte interactions

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-alpha inhibitor

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoform-selective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Triggering CD40 on endothelial cells contributes to tumor growth

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

PECAM-1 (CD31) expression in the central nervous system and its role in experimental allergic encephalomyelitis in the rat.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Induction of beta-chemokine secretion by human brain microvessel endothelial cells via CD40/CD40L interactions.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

A controlled trial of natalizumab for relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Immunology of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

A monoclonal antibody to alpha 4-integrin reverses the MR-detectable signs of experimental allergic encephalomyelitis in the guinea pig

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

The spectrum of multiple sclerosis and treatment decisions

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Pathogenesis of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Natalizumab and progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Statins in the treatment of central nervous system autoimmune disease

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1alpha or its CCR5 receptor

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

CD40 expression by microglial cells is required for their completion of a two-step activation process during central nervous system autoimmune inflammation

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Distinct chemokine receptor and cytokine expression profile in secondary progressive MS

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Exclusive tumor necrosis factor (TNF) signaling by the p75TNF receptor triggers inflammatory ischemia in the CNS of transgenic mice.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Treatment with an estrogen receptor alpha ligand is neuroprotective in experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Monocyte/macrophage differentiation in early multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

In vivo blockade of macrophage migration inhibitory factor ameliorates acute experimental autoimmune encephalomyelitis by impairing the homing of encephalitogenic T cells to the central nervous system

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Glatiramer acetate therapy for multiple sclerosis: a review.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

The CCR5 deletion mutation fails to protect against multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Targeting leukocyte trafficking to inflamed skin: still an attractive therapeutic approach?

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Three allele combinations associated with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Interaction of alpha4-integrin with VCAM-1 is involved in adhesion of encephalitogenic T cell blasts to brain endothelium but not in their transendothelial migration in vitro.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Putative mechanisms of action of statins in multiple sclerosis--comparison to interferon-beta and glatiramer acetate

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

The safety profile of cyclophosphamide in multiple sclerosis therapy

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

CD40L blockade prevents autoimmune encephalomyelitis and hampers TH1 but not TH2 pathway of T cell differentiation

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

The role of inflammation in CNS injury and disease

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

The blood-brain barrier: an overview: structure, regulation, and clinical implications

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Lymphocyte homing and homeostasis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Oral fingolimod (FTY720) for relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Downregulation of matrix metalloproteinase-9 and attenuation of edema via inhibition of ERK mitogen activated protein kinase in traumatic brain injury

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

TCR peptide vaccination in multiple sclerosis: boosting a deficient natural regulatory network that may involve TCR-specific CD4+CD25+ Treg cells

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Intensive immunosuppression in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

The dynamic co-evolution of memory and regulatory CD4+ T cells in the periphery

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Normal Th1 development following long-term therapeutic blockade of CD154-CD40 in experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Association of CCR5 delta32 deletion with early death in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Molecular mechanisms involved in T cell migration across the blood-brain barrier.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Toward a role for statins in immunomodulation

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Cerivastatin suppresses lipopolysaccharide-induced ICAM-1 expression through inhibition of Rho GTPase in BAEC

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Regulation of SDF-1 (CXCL12) production by osteoblasts; a possible mechanism for stem cell homing.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Intercellular adhesion molecule-1 expression is required on multiple cell types for the development of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Statin therapy and autoimmune disease: from protein prenylation to immunomodulation

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

A critical role for OX40 in T cell-mediated immunopathology during lung viral infection

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Effect of atorvastatin on adhesive phenotype of human endothelial cells activated by tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Blockade of chemokine signaling in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Evaluation of HMG-CoA reductase inhibitors for multiple sclerosis: opportunities and obstacles

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Chemokines in rapid leukocyte adhesion triggering and migration

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Induction of a non-encephalitogenic type 2 T helper-cell autoimmune responsein multiple sclerosis after administration of an altered peptide ligand ina placebo-controlled, randomized phase II trial

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Molecular mechanisms involved in lymphocyte recruitment in inflamed brain microvessels: critical roles for P-selectin glycoprotein ligand-1 and heterotrimeric G(i)-linked receptors

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Arvanil inhibits T lymphocyte activation and ameliorates autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Immunological profile of patients with primary progressive multiple sclerosis. Expression of adhesion molecules

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Interferon-beta directly influences monocyte infiltration into the central nervous system.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Lovastatin inhibits brain endothelial cell Rho-mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Autoimmune intervention by CD154 blockade prevents T cell retention and effector function in the target organ

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Th17: an effector CD4 T cell lineage with regulatory T cell ties

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Polyclonal expansion of regulatory T cells interferes with effector cell migration in a model of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

CD134 plays a crucial role in the pathogenesis of EAE and is upregulated in the CNS of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: imbalance of Th1/Th2-associated chemokine signaling

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

CD40 expressed by human brain endothelial cells regulates CD4+ T cell adhesion to endothelium

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Heightened intrathecal release of soluble CD137 in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R+WIN55,212

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

MRI reveals that early changes in cerebral blood volume precede blood-brain barrier breakdown and overt pathology in MS-like lesions in rat brain.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Soluble vascular cell adhesion molecule (VCAM) is associated with treatment effects of interferon beta-1b in patients with secondary progressive multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Migration of multiple sclerosis lymphocytes through brain endothelium.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000397

7 January 2021

10.1017/S1462399407000397

Identifiers

DOI

0 references

1 reference